American Century Companies’s Day One Biopharmaceuticals DAWN Stock Holding History

American Century Companies's DAWN Position: Q2 2026 in Review

American Century Companies sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 88,278 shares — an estimated $1.89M sold.

American Century Companies first reported a position in DAWN in Q1 2025 and held it in 5 quarters. The position peaked at $1.89M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

• American Century Companies reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
• American Century Companies sold 88,278 Day One Biopharmaceuticals shares in Q2 2026, an estimated $1.89M.
• American Century Companies first reported a position in Day One Biopharmaceuticals in Q1 2025 and held it in 5 quarters.
• American Century Companies's Day One Biopharmaceuticals position peaked at $1.89M in Q1 2026.
• 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.